Dynasil Biomedical

Dynasil Biomedical Corporation is a medical technology company focused on the development of advanced surgical sealants and hemostatic agents. The company's flagship product, X-Seal, is a proprietary "smart" polymer-based sealant designed to provide rapid and durable closure of surgical wounds and internal tissue leaks. Developed in collaboration with the Mayo Clinic and Beth Israel Deaconess Medical Center, the technology is engineered to perform effectively in wet and high-pressure physiological environments where traditional fibrin glues often fail. Dynasil Biomedical was a subsidiary of Dynasil Corporation of America until its acquisition by Gooch & Housego in 2022. The company's research integrates material science and biotechnology to address critical unmet needs in surgical care and wound management.